Name: The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May.
Uploaded: 2023-06-16T14:03:01.009383+00:00
Duration: 1657 s
Channel: Vox Markets
Description: The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May.

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/005/909/005909/video_BjscQ0v.mp4#t=207

Vox Markets

The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May.

Why the long-term case for commodities remains intact despite recent share price weakness across the sector as a result of current investor worries about the threat of recession.

The potential impact of the need for capital investment in new production on the current high cashflows and dividends of miners.

Bioventix (BVXP) and investing in healthcare via the picks and shovels approach.

The importance of assessing the impact of AI on portfolio companies, positively and negatively, and the case for selling CentralNic (CNIC).

The rationale behind new purchases including IC Group (IGG) and “quality compounder” RS Group (RS1), formerly Electrocomponents.

Translation specialist RWS (RWS) as an example of the difficulties in assessing AI’s impact

Why John’s bought “boring” oversold Unilever (ULVR) on the back of recent price weakness.

The tailwinds that have taken the portfolio back above £600k, including Me Group’s (MEGP) ongoing transformation into a cash generating machine.

Shoe Zone (SHOE) and its continuing earnings upgrade cycle and further buybacks.

How the huge drop in the cost of shipping has helped Shoe Zone, and the potential read-across to IG Design (IGR)

Serica Energy’s (SQZ) bounce back from its March low point

In our latest monthly catch-up with top private investor John Rosier gives us his latest portfolio update, and how June has brought respite after a May to forget.

In our latest monthly catch-up with top private investor John Rosier gives us his latest portfolio update, and how June has brought respite after a May to forget. Includes a look at the commodities balancing act between economic weakness and long-term supply deficits, the best ways to invest in healthcare, and assessing the AI threat. 


1.08 Why the long-term case for commodities remains intact despite recent share price weakness across the sector as a result of current investor worries about the threat of recession.
3:27 The potential impact of the need for capital investment in new production on the current high cashflows and dividends of miners.
4:58 The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May.
7.52 Bioventix (BVXP) and investing in healthcare via the picks and shovels approach.
11:36 The importance of assessing the impact of AI on portfolio companies, positively and negatively, and the case for selling CentralNic (CNIC). 
14:52 Translation specialist RWS (RWS) as an example of the difficulties in assessing AI’s impact 
13:50 The rationale behind new purchases including IC Group (IGG) and “quality compounder” RS Group (RS1), formerly Electrocomponents.
18:20 Why John’s bought “boring” oversold Unilever (ULVR) on the back of recent price weakness.
21:55 The tailwinds that have taken the portfolio back above £600k, including Me Group’s (MEGP) ongoing transformation into a cash generating machine. 
23:50 Shoe Zone (SHOE) and its continuing earnings upgrade cycle and further buybacks.
24:50 How the huge drop in the cost of shipping has helped Shoe Zone, and the potential read-across to IG Design (IGR)
26.45 Serica Energy’s (SQZ) bounce back from its March low point

In our latest monthly catch-up with top private investor John Rosier gives us his latest portfolio update, and how June has brought respite after a May to forget.In our latest monthly catch-up with top private investor John Rosier gives us his latest portfolio update, and how June has brought respite after a May to forget. Includes a look at the commodities balancing act between economic weakness and long-term supply deficits, the best ways to invest in healthcare, and assessing the AI threat. 1.08 Why the long-term case for commodities remains intact despite recent share price weakness across the sector as a result of current investor worries about the threat of recession. 3:27 The potential impact of the need for capital investment in new production on the current high cashflows and dividends of miners. 4:58 The investment case for Niox (NIOX) – an asthma diagnostics company - on of the JIC portfolio’s best performing investments in May. 7.52 Bioventix (BVXP) and investing in healthcare via the picks and shovels approach. 11:36 The importance of assessing the impact of AI on portfolio companies, positively and negatively, and the case for selling CentralNic (CNIC). 14:52 Translation specialist RWS (RWS) as an example of the difficulties in assessing AI’s impact 13:50 The rationale behind new purchases including IC Group (IGG) and “quality compounder” RS Group (RS1), formerly Electrocomponents. 18:20 Why John’s bought “boring” oversold Unilever (ULVR) on the back of recent price weakness. 21:55 The tailwinds that have taken the portfolio back above £600k, including Me Group’s (MEGP) ongoing transformation into a cash generating machine. 23:50 Shoe Zone (SHOE) and its continuing earnings upgrade cycle and further buybacks. 24:50 How the huge drop in the cost of shipping has helped Shoe Zone, and the potential read-across to IG Design (IGR) 26.45 Serica Energy’s (SQZ) bounce back from its March low point

https://d3ev5earl6dvd0.cloudfront.net/public-media/videos/005/909/005909/video_BjscQ0v.mp4